Lipids in Health and Disease

OCT 3, 2026 · JOURNAL ARTICLE

Dynamic associations of the cholesterol, high-density lipoprotein, and glucose index and its obesity-related indices with the incidence and progression of cardiometabolic multimorbidity: evidence from the CHARLS and ELSA cohorts

Lipids in Health and Disease

Cardiometabolic multimorbidity (CMM) is a major global public health challenge associated with metabolic dysregulation and obesity. Cholesterol, high-density lipoprotein cholestero

OCT 1, 2026 · JOURNAL ARTICLE

Lipid metabolic reprogramming of innate immune cells in breast cancer and its implications for tumor metastasis and therapy

Lipids in Health and Disease

Lipid metabolism is increasingly recognized as a central regulator of the breast tumor microenvironment (TME), affecting disease progression, immune escape, metastatic spread, and

SEP 25, 2026 · JOURNAL ARTICLE

Postprandial lipopolysaccharide after a saturated compared to monounsaturated fatty acid enriched high fat meal in older adults: a randomized control trial

Lipids in Health and Disease

Lipopolysaccharide (LPS), derived from gram-negative bacteria, is associated with inflammation. Serum LPS concentrations modestly rise after high-fat meals, known as metabolic endo

SEP 11, 2026 · JOURNAL ARTICLE

Interpreting the role of lipoprotein(a) in metabolic disorders: current evidence and future perspectives

Lipids in Health and Disease

Lipoprotein(a) [Lp(a)] consists of an LDL-like particle that is covalently linked to apolipoprotein(a) [Apo(a)] through a disulfide bond. An elevated Lp(a) level is causally implic

SEP 2, 2026 · JOURNAL ARTICLE

Placental sphingolipids are altered by maternal obesity and GDM and associated with fetal overgrowth

Lipids in Health and Disease

Observational study of placental lipid composition in a cross-sectional design with correlational analysis; no causal mechanism established and no intervention or clinical outcome tested.

AUG 8, 2026 · JOURNAL ARTICLE

TyG-Biomarker discordance profiling identifies metabolically heterogeneous phenotypes with divergent cardiovascular and diabetes risk: metabolomic characterization from the UK biobank

Lipids in Health and Disease

A large observational study identifying reproducible metabolic phenotypes with divergent clinical associations, supported by metabolomic validation, but lacking experimental intervention or prospective risk prediction validation.